Related by context. Frequent words. (Click for all words.) 68 novel anti infective 68 oncolytic virus therapies 68 Sangamo ZFP technology 68 optical biosensors 68 Initiates Phase II 67 regarding Aethlon Medical 66 LEX System 66 therapeutic monoclonal antibodies 66 technology platforms photodynamic 65 Completes Patient Enrollment 65 liposomal formulation 65 siRNA therapeutic 65 ZFN TM 65 MEK inhibitors 65 novel RNAi therapeutics 64 inflammatory autoimmune diseases 64 peripherally acting 64 VEGFR2 inhibitor 64 activity dependent neuroprotective 64 BiTE R 64 New Chemical Entities 64 SNALP technology 64 topically delivered 64 stable nucleic acid 63 R sorafenib tablets 63 PSMA ADC 63 Romidepsin 63 Kinase Inhibitor 63 orally bioavailable 63 PEGylation technology 63 Medarex applies 63 biomarker assays 63 Receives Orphan Drug Designation 63 novel antibody therapeutics 63 TLR9 agonists 63 Factor VIIa 63 leading lipid nanoparticle 63 NNRs 63 Inc. NASDAQ TRGT 63 proteasome inhibitor 62 TLR8 62 CCX# 62 Thiarabine 62 multivalency toward drug 62 TLR9 agonist 62 2 methoxyestradiol 62 TELINTRA 62 sorafenib tablets 62 phage display 62 molecular biomarkers 62 ® bortezomib 62 TRAIL receptor antibodies 62 selective inhibition 62 epothilone 62 SARMs 62 boron chemistry 62 anticancer compounds 62 targeting CD# 62 Tesetaxel 62 AeroLEF R 62 immunotherapeutics 62 Small Molecule 62 histone deacetylase HDAC inhibitors 62 Lipid Polymer Micelle LPM 62 humanized anti 61 Amgen discovers develops 61 Sapacitabine 61 Nanobody 61 orBec ® oral beclomethasone 61 cancer immunotherapies 61 novel orally administered 61 MKC# 61 nitric oxide donating 61 Panzem R 61 refractory chronic lymphocytic 61 JAK1 61 non personalized allogeneic 61 Monoclonal Antibody 61 Symadex 61 www.syntapharma.com 61 KL4 surfactant 61 Completes Enrollment 61 Prodarsan ® 61 promising anticancer 61 proprietary Mimetic Ligand 61 Initiates Phase 61 selectively inhibit 61 Trofex 61 Recombinant Human 61 Commences Phase 61 generation antisense 61 genomic proteomic 61 Epidermal Growth Factor Receptor 61 * Azixa 61 selective inhibitors 61 ZFP Therapeutics 61 Tumor Necrosis Factor 60 immunotherapeutic agent 60 neuroprotective properties 60 ZFP technology 60 Helix BioMedix Inc.